Drug Type Small molecule drug |
Synonyms JYP 0061, JYP-0061, JYP0061 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 2 | CN | 09 Nov 2023 | |
Neuromyelitis Optica | Phase 2 | CN | 17 May 2023 | |
AxSpA | IND Approval | CN | 06 Mar 2024 | |
Demyelinating Diseases | IND Approval | CN | 10 Mar 2022 | |
Rheumatoid Arthritis | IND Approval | CN | 08 Sep 2021 |